Search hospitals > Colorado > Longmont
Rocky Mountain Cancer Centers-Longmont
Claim this profileLongmont, Colorado 80501
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Pancreatic Cancer
192 reported clinical trials
8 medical researchers
Summary
Rocky Mountain Cancer Centers-Longmont is a medical facility located in Longmont, Colorado. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Rocky Mountain Cancer Centers-Longmont is involved with conducting 192 clinical trials across 372 conditions. There are 8 research doctors associated with this hospital, such as Richard L. Deming, Nicholas DiBella, Allen L. Cohn, and David J Andorsky.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage II
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Richard L. DemingMercy Medical Center - Des Moines6 years of reported clinical research
Expert in Breast Cancer
Expert in Cancer
178 reported clinical trials
242 drugs studied
Nicholas DiBellaRocky Mountain Cancer Centers-Boulder6 years of reported clinical research
Expert in Breast Cancer
Expert in Lung Cancer
103 reported clinical trials
193 drugs studied
Allen L. CohnRocky Mountain Cancer Centers3 years of reported clinical research
Studies Colorectal Cancer
Studies Cancer
18 reported clinical trials
36 drugs studied
David J AndorskyRocky Mountain Cancer Centers USOR4 years of reported clinical research
Studies Follicular Lymphoma
Studies Chronic Illness
10 reported clinical trials
14 drugs studied
Clinical Trials running at Rocky Mountain Cancer Centers-Longmont
Bladder Cancer
Lung Cancer
Breast Cancer
Prostate Cancer
Breast cancer
Bladder Carcinoma
Multiple Myeloma
Esophageal cancer
Testicular cancer
Cancer
Gemcitabine + Docetaxel vs BCG
for Bladder Cancer
This trial is testing whether a combination of two drugs, Gemcitabine and Docetaxel, given directly into the bladder, is effective for patients with high-grade non-muscle invasive bladder cancer who have not been treated with the standard therapy before. The goal is to see if this new treatment can prevent cancer from coming back or spreading. The study will also look at the quality of life, safety, and side effects of the new treatment. Gemcitabine and Docetaxel have shown promise as an alternative treatment, especially in cases where the standard therapy fails or is not tolerated.
Recruiting2 awards Phase 314 criteria
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
Blood Sample Collection
for Cancer Detection
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Recruiting1 award N/A9 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Rocky Mountain Cancer Centers-Longmont?
Rocky Mountain Cancer Centers-Longmont is a medical facility located in Longmont, Colorado. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Rocky Mountain Cancer Centers-Longmont is involved with conducting 192 clinical trials across 372 conditions. There are 8 research doctors associated with this hospital, such as Richard L. Deming, Nicholas DiBella, Allen L. Cohn, and David J Andorsky.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.